Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Professional regulation

Liberal Democrat peer to lead revalidation advisory group

Liberal Democrat peer Lord Kirwood of Kirkhope has been appointed independent chairman of a group set up to provide expert advice to pharmacy regulators about continuing fitness-to-practise reforms.

Kirkwood, who trained as a pharmacist and lawyer and was MP for Roxburgh and Berwickshire from 1983 until 2005 when he became a life peer, will be paid £500 a day for a maximum ten days’ work a year as he helps steer the General Pharmaceutical Council (GPhC) through the changes.

The reforms will introduce new ways to assess the continuing fitness to practise of pharmacists, a process also known as revalidation. They are expected to be implemented in 2018.

Lord Kirwood says it is important the GPhC achieves “patient-centred professionalism”, adding: “My role is to achieve a common view on how to achieve this without having a negative impact on improving services to patients and other service users.”

Nigel Clarke, chairman of the GPhC, says Lord Kirwood has a responsibility to bring together all stakeholder views “helping to make sure that the new arrangements are effective, while not placing a disproportionate burden on pharmacy professionals and their employers”.

The appointment was announced as the GPhC published a slightly revised timetable for introducing its reformed continuing fitness-to-practise arrangements.

The overall date for implementation in 2018 and the 2017 deadline for consultation and preparation remain the same. Testing and piloting will take place between 2015/2016 and 2016/2017, slightly later than originally planned. 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20066919

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.